Showing results (1031-1040 of 1,193) with videos related to

Sort By:
Pageof 120
Blood Advances|January 9, 2025
Advancing drug development in myelodysplastic syndromesAlain Mina, Kathy L McGraw, Lea Cunningham, et al.
Blood|March 29, 2024
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALLYaqi Zhao, Nicholas J Short, Hagop M Kantarjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2024
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AMLNicholas J Short, Naval Daver, Courtney D Dinardo, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALLYaqi Zhao, Nicholas J Short, Hagop M Kantarjian, et al.
NEJM Evidence|February 6, 2024
Low-Dose Decitabine versus Low-Dose Azacitidine in Lower-Risk MDSKoji Sasaki, Elias Jabbour, Guillermo Montalban-Bravo, et al.
Frontiers in Immunology|October 16, 2023
Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of conceptMuhammad Aminu, Naval Daver, Myrna C B Godoy, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 17, 2026
Treatment in Clinical Trials Could Mitigate Socioeconomic and Racial Disparities in Acute Myeloid LeukemiaMahesh Swaminathan, Hussein A Abbas, Michael Roth, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2021
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology GroupRashmi Kanagal-Shamanna, Attilio Orazi, Robert P Hasserjian, et al.
Frontiers in Oncology|February 15, 2021
Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline AlterationsSarah A Bannon, Mark J Routbort, Guillermo Montalban-Bravo, et al.
Haematologica|December 12, 2024
Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neoplasmsJayastu Senapati, Sanam Loghavi, Guillermo Garcia-Manero, et al.
Pageof 120